Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Chemoradiotherapy × Clear all

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Conditions

Lung Neoplasms 3 Glioblastoma 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Radiation Injuries 1 Ototoxicity 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphatic Metastasis 1 Locally Advanced Cervical Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hearing Loss 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Cognitive Dysfunction 1 Cholangiocarcinoma 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Surveys and Questionnaires 71 Blood Specimen Collection 45 Interviews as Topic 24 Data Collection 15 Radiotherapy 12 Observation 11 Magnetic Resonance Spectroscopy 11 Exercise 11 Watchful Waiting 9 Hematologic Tests 9 Drug Therapy 9 Quality of Life 8 Therapeutics 6 Specimen Handling 6 Focus Groups 6 Biopsy 6 Phlebotomy 5 Magnetic Resonance Imaging 5 Lapatinib 5 pembrolizumab 4 Trastuzumab 4 Standard of Care 4 Restraint, Physical 4 Palliative Care 4 Nivolumab 4 Neoadjuvant Therapy 4 Mental Status and Dementia Tests 4 Ipilimumab 4 High-Throughput Nucleotide Sequencing 4 Base Sequence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡